IP Library Granted Patent US 9,777,280
Granted Patent B2
US 9,777,280 · App. 15/060,036 · Granted Oct 3, 2017

Compositions and methods for 3-hydroxypropionic acid production

Inventors: Holly Jessen (Chanhassen, MN); Brian Rush (Minneapolis, MN); Jeanette Huryta (Excelsior, MN); Beth Mastel (Excelsior, MN); Alan Berry (Granite Bay, CA); Debbie Yaver (Davis, CA); Michael Catlett (West Sacramento, CA); Michelle Barnhart (Sacramento, CA)
Assignee: CARGILL, INCORPORATED
C12N15/52C12N1/18C12N9/0006C12N9/1096C12N9/88C12N9/93C12N15/81C12N15/815C12P7/42C12Y101/01059C12Y206/01001C12Y206/01018C12Y206/01019C12Y401/01031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,777,280
App. No.
15/060,036
Granted
Oct 3, 2017
Kind
B2
Abstract

The present application discloses genetically modified yeast cells comprising an active 3-HP fermentation pathway, and the use of these cells to produce 3-HP.

Claims (5)

1. A genetically modified yeast cell selected from the group consisting of I. orientalis, C. lambica , and S. bulderi , the genetically modified yeast cell comprising an active 3-HP fermentation pathway, wherein the cell comprises an exogenous BAAT or gabT gene encoding an enzymatically active polypeptide with at least 85% sequence identity to an amino acid sequence selected from SEQ ID NOs: 20, 21, and 24.

2. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 90% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24.

3. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 95% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24.

4. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 97% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24.

5. The genetically modified yeast cell of claim 1 , wherein the BAAT or gabT gene encodes a polypeptide having at least 98% sequence identity to the amino acid sequence selected from SEQ ID Nos: 20, 21, and 24.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: BERRY, ALAN; YAVER, DEBBIE; CATLETT, MICHAEL; BARNHART, MICHELLE
To: NOVOZYMES, INC.
Reel/Frame 043129/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: JESSEN, HOLLY JEAN; RUSH, BRIAN J.; HURYTA, JEANETTE; MASTEL, BETH
To: CARGILL, INCORPORATED
Reel/Frame 043130/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: NOVOZYMES, INC.
To: NOVOZYMES A/S
Reel/Frame 043132/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2017
From: NOVOZYMES A/S
To: CARGILL INCORPORATED
Reel/Frame 043132/0282 →
Continuity (5)
Continuation 14073441 · Nov 6, 2013
Continuation 13301556 · Nov 21, 2011
Provisional Application 61535181 · Sep 15, 2011
Provisional Application 61416199 · Nov 22, 2010
Related Publication 20160177317A1 · Jun 23, 2016